TrademarkIQ íconeTrademarkIQ
Voltar para busca

Brasil501542011

novo nordisk

Novo Nordisk A/S

Registro de marca em vigor (Madri)Classe 1Classe 5Classe 9Classe 10Classe 41Classe 42Classe 44Mista

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

novo nordisk

Andamento no INPI

  1. Vigente03/04/30

Registro concedido em 27/07/2021 e em vigor até 03/04/2030, quando precisa ser renovado.

Proteção válida até:03/04/2030

AlertaMarcas

Receba uma proposta de Vigilância

A Vigilância é um serviço pago de acompanhamento semanal: analisamos marcas parecidas a cada RPI, apontamos ameaças e prazos e damos acesso a um portal. Enviamos a proposta por e-mail.

Usamos seus dados apenas para enviar a proposta.

Última movimentação publicada pelo INPI: 14/06/2022. Atualizamos a cada nova RPI, publicada semanalmente.

Classificação técnica

Códigos Vienna

27.5.13.4.129.1.426.1.426.1.1

Produtos e serviços

Classe 1

Chemical preparations for use in industrychemical additiveschemical additives for use in the manufacture of pharmaceuticals, cosmetics, hair lotions, disinfectantschemical diagnostic reagents for industrial usechemical preparations for use in the oil industry

Classe 5

Pharmaceutical preparations for the treatment of diabetes and obesitypharmaceutical preparations for haemostasis management and for the treatment of sickle cell diseasepharmaceutical preparations for the treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney diseasepharmaceutical preparations for hormone therapy and stem cells for medical purposesdrug delivery devices containing the abovementioned productschemical preparations for use in medical devices

Classe 9

Electronic publications, namely, leaflets, books, booklets, handouts, magazines as well as medical, instructional and teaching material in the field of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatmentdownloadbale electronic publications featuring electronic reports containing results from clinical trials and studies in the field of prevention and treatment of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatmentsoftware applications for use with mobile devices for monitoring and the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatmentcomputer hardware and software, for use with medical injection devices for collecting, transmitting, and displaying medical datamedical software for the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatmentsoftware as a medical device

Classe 10

Medical and surgical apparatus and instruments, namely, hypodermic syringes and pensmedical apparatus and instruments for reconstitution and injection of pharmaceutical preparationsmedical apparatus and instruments, namely, injection devices for administration of pharmaceutical preparations, medical infusion pumps, infusion pump controllers, adhesive infusion devicesdigitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatmentmedical and surgical apparatus and instruments, namely, injection devices for the administration of pharmaceutical preparations and the wireless transmission of medical data in connection with the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatmentmedical devices, namely, automatic needle insertion devices, protection caps for hypodermic syringes and medical pensneedles for injectionscartridges and carpules for administration pharmaceutical preparations

Classe 41

Educational services, namely, organizing and conducting educational programmes, coaching and training services for patients and healthcare professionals related to management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatmentarranging and conducting of conferences, congresses, seminars, symposiums and workshops related to the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment

Classe 42

Providing scientific information on diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatmentproviding websites and mobile apps featuring technology that enables users to record, track, and generate reports regarding the condition, treatment and the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatmentcomputer services, namely providing access to data concerning medical analysis and management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment

Classe 44

Providing medical services via websites and mobile apps for the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatmentproviding medical information and medical counselling the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment

Publicações

Histórico de despachos e eventos da marca no INPI.

4 publicações encontradas

14/06/2022

RPI 2684

Deferimento da petição

IPAS270

Protocolo: 850220217381 (24/05/2022) Petição (tipo): Nomeação, destituição ou substituição de procurador [em processo de registro] (385.1) Requerente: NOVO NORDISK A/S Procurador: MMV Agentes da Propriedade Industrial Ltda. Detalhes do despacho:Nomeado procurador MMV Agentes da Propriedade Industrial Ltda com poderes para representar o titular do processo perante o INPI.

27/07/2021

RPI 2638

Concessão de registro em designação

IPAS770

13/04/2021

RPI 2623

Deferimento de designação

IPAS768

01/09/2020

RPI 2591

Publicação de pedido de registro para oposição (exame formal de designação concluído)

IPAS756

Inteligência publicitária

Um anunciante usa este nome e não é o titular desta marca

  • NOVO NORDISK FARMACEUTICA DO BRASIL LTDA

    CNPJ 82.277.955/0002-36 · SÃO PAULO/SP

    12 filmes publicitários · 2020–2024

Empresa(s) a investir em publicidade com este nome sem deter este registro — possível uso por terceiro ou conflito de marca. Recomenda-se verificação especializada.

Inteligência publicitária TrademarkIQ. Sinal informativo — confirme a titularidade antes de qualquer ação.

Novo Nordisk A/S também protege tecnologia e design no INPI

527 pedidos de patente e 3 desenhos industriais no mesmo titular.

novo nordisk - Processo 501542011 | Marca no INPI | TrademarkIQ